Massive data dive: which diabetes drug protects hearts better?
NCT ID NCT07203677
Summary
This study used health insurance records from nearly 50,000 people to compare two common diabetes medications, tirzepatide and sitagliptin. The goal was to see which drug is more effective at preventing serious heart problems like heart attacks and strokes in people who have both type 2 diabetes and heart disease. Researchers analyzed past patient data instead of giving new treatments, aiming to provide clearer guidance for doctors and regulators.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02120, United States
Conditions
Explore the condition pages connected to this study.